fungal; innate immunity; matrix metalloproteinase 12 CHRONIC OBSTRUCTIVE PULMONARY disease (COPD; emphysema) is estimated to affect over 200 million people worldwide (2) . Global Burden of Disease assessment by the World Health Organization placed COPD as the sixth leading cause of death in 1990, which increased to fourth in 2004 where it is projected to remain through 2030 (20) . In regards to the contribution of cigarette smoking, the most prominent risk factor for the development of COPD, estimates range from 20% to up to 90% of smokers who will go on to develop COPD (reviewed in Ref. 37 ). The consequences of cigarette smoke culminate in exaggerated chronic lung inflammation, an imbalance between proteases and antiproteases, an imbalance between oxidants and antioxidants, and a lack of alveolar structural cell repair after damage (reviewed in Ref. 2) . These components in turn contribute to chronic cough and sputum production that ultimately leads to a decrease in the forced expiratory volume in 1 s (FEV 1 ) compared with predicted FEV 1 (18) .
Based on observations that individuals deficient in ␣ 1 -antitrypsin develop COPD early in life (17) , there has been intensive investigations into protease biology. These studies have identified roles for matrix metalloproteinase (MMP) 1, MMP2, MMP9, and MMP12 and a disintegrin and metalloproteases 17 (ADAM17) and ADAM33 in the pathogenesis of COPD (reviewed in Ref. 24) . With respect to MMP12, also known as macrophage elastase, mice deficient in this protease demonstrate resistance to cigarette smoke-induced emphysema (11) , whereas transgenic overexpression of MMP12 in the lungs of mice accelerates emphysema and the development of bronchoalveolar adenocarcinoma (30) . MMP12 is overexpressed in smokers with COPD (8) , and a specific SNP in the Mmp12 promoter associated with higher MMP12 activity has demonstrated faster FEV 1 decline in a cohort of current smokers with mild to moderate airway obstruction (13) . A recent study examining MMP12 in COPD and asthma reported that, in patients with COPD, disease severity, when measured by means of CT-assessed emphysema, but not by means of spirometry or Dlco values, was directly associated with sputum MMP12 concentrations and activity (4) .
Exacerbations in COPD are often thought to be microbial in origin (32) . Over a decade ago, the "vicious circle hypothesis" was proposed, which states that cigarette smoke impairs innate lung defenses allowing microbial pathogens to become established in the lower respiratory tract, leading to chronic inflammation and lung destruction (31) . Recent studies have revealed that HIV-positive individuals have an accelerated form of emphysema (9) and a high prevalence of COPD (7) . Although the mechanism(s) for this is unknown, it has been hypothesized that subclinical pulmonary infections could be involved. In turn, the atypical fungal organism Pneumocystis jirovecii is increasingly becoming associated with COPD in both non-HIV and HIV patients (26, 27, 36) . We have recently determined that HIV-positive individuals colonized with Pneumocystis had worse airway obstruction in the presence of higher levels of MMP12, but not MMP1, MMP2, or MMP9, in sputum compared with noncolonized HIV-positive individuals (25) . In the current study, we characterized the induction of and role for MMP12 in the lung response to experimental Pneumocystis lung infection in mice.
MATERIALS AND METHODS
Mice. Male C57BL/6 or Balb/c mice, 6 -8 wk of age, were purchased from the National Cancer Institute, National Institutes of Health (Bethesda, MD) or from Jackson Laboratories (Bar Harbor, ME P. murina inoculation and lung burden quantification. A preparation of P. murina was prepared as previously described (16) . Briefly, C.B-17 SCID mice previously inoculated with P. murina were injected with a lethal dose of ketamine/xylazine, and the lungs were aseptically removed and frozen at Ϫ80°C in 1 ml PBS. Frozen lungs were homogenized through a 70-m filter and pelleted at 300 g for 10 min at 4°C. The pellet was resuspended in 1 ml of PBS, and a 1:10 dilution was stained with modified Giemsa stain (Diff-Quik). The number of P. murina cysts was quantified microscopically, and the concentration was adjusted to 2 ϫ 10 6 cysts/ml. For in vivo challenge, mice were anesthetized with isoflurane and administered 2 ϫ 10 5 cysts in a volume of 0.1 ml via intratracheal inoculation. Some preparations were also adjusted to 2 ϫ 10 6 cysts/ml, and 50-l aliquots were placed in tubes containing 200 l of 90% FBS supplemented with 10% dimethyl sulfoxide and stored at Ϫ80°C. Employing this storage method, stable P. murina viability, as determined by quantitative real-time PCR, can be maintained for greater than one year (38) . In some experiments, mice were depleted of CD4 T cells via intraperitoneal injections of GK 1.5 monoclonal antibody as described (22) . For lung fungal burden analysis, total RNA was isolated from the right lung of infected mice by a single-step method using TRIzol reagent (Invitrogen Life Technologies) per the manufacturer's instructions. Thereafter, RNA was transcribed to cDNA, and real-time PCR for Pneumocystis rRNA was performed as described previously (39, 41) .
Alveolar macrophage isolation and culture. Naïve mice were anesthetized with intraperitoneal ketamine/xylazine and killed by exsanguination. Thereafter, lungs were lavaged through an intratracheal catheter with prewarmed (37°C) calcium-and magnesium-free PBS supplemented with 0.6 mM EDTA. A total of 10 ml were used in each mouse in 0.5-ml increments with a 30-s dwell time. The lavage fluids were pooled and centrifuged at 600 g for 10 min, and the cells were collected for the coculture assay. Cell preparations were generally Ͼ98% enriched for alveolar macrophages (AMs). Macrophages (1 ϫ 10 5 in 100 l) were left alone or treated with 10 ng/ml of interleukin (IL)-4 or interferon (IFN)-␥ (both from eBioscience) for 4 h (RNA) or 24 h (cell lysate).
Real-time PCR analysis for Mmp12 expression in AMs and lung tissue. Mice were infected with P. murina for 7 or 14 days followed by either lung lavage or lung tissue collection. Lung lavage cells were adhered to plastic for 1 h at 37°C in 5% CO2 (to enrich for AMs) followed by the removal of nonadherent cells. Total RNA was isolated from enriched AMs or the right lung of infected mice by a single-step method using TRIzol reagent as per the manufacturer's instructions. Thereafter, RNA was transcribed to cDNA (iScript cDNA synthesis kit; Bio-Rad), and real-time PCR for MMP12 (Mm00500554_m1; Applied Biosystems) was performed (iQ Supermix; Bio-Rad). mRNA levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels (primers/probe from Applied Biosystems) using the 2
Analysis of MMP12 protein expression. AMs were isolated as described and cultured overnight in the presence of recombinant murine IL-4 or IFN-␥ (eBioscience, San Diego, CA) for 24 h. Thereafter, cell lysates were extracted using PhosphoSafe extraction buffer (Novagen, San Diego, CA) and clarified by centrifugation, and total protein concentration was determined using a BCA Protein Assay Kit as per the manufacturer's instructions (Pierce, Rockford, IL). Ten micrograms of each lysate were separated on 4 -12% Bis-Tris SDS-PAGE gels (Invitrogen, Carlsbad, CA), transferred to a polyvinylidene difluoride (PVDF) membrane, and blocked with 5% skim milk overnight at 4°C. Thereafter, the PVDF membrane was incubated with goat polyclonal anti-MMP12 (Santa Cruz Biotechnology, Santa Cruz, CA) or mouse monoclonal anti-GAPDH (Ambion, Austin, TX) in 2% skim milk (all primary antibodies used at 1:1,000, 2 h at room temperature) followed by horseradish peroxidase-conjugated donkey anti-goat IgG (at 1:2,000) or horseradish peroxidase-conjugated goat anti-mouse IgG (at 1:5,000) for 2 h at room temperature (Bio-Rad, Hercules, CA). Positive bands were identified using an ECL Western blot detection kit (Amersham Biosciences, Piscataway, NJ). Quantity One 1-D Analysis Software (Bio-Rad) was used to generate densitometry data from MMP12 and GAPDH controls between untreated and IL-4/IFN-␥-treated AMs.
Statistical analysis. Data were analyzed using GraphPad Prism statistical software (GraphPad Software, San Diego, CA). Comparisons between groups when data were normally distributed were made with the two-tailed unpaired Student's t-test and the two-tailed MannWhitney U-test when not normally distributed. In real-time PCR and Western blot analyses, the two-tailed paired Student's t-test was employed. Significance was accepted at a value of P Ͻ 0.05.
RESULTS

P. murina lung exposure results in the induction of Mmp12.
In our previous study, we observed that P. jirovecii colonization was associated with worse airway obstruction in HIVinfected subjects and correlated with increased levels of MMP12 in sputum (25) . In an effort to better understand this correlation, we took a "bedside to bench" approach and questioned whether lung exposure to Pneumocystis (P. murina) induced Mmp12 mRNA expression in a murine model. For this, C57BL/6J mice (Jackson) were challenged with P. murina for 7 and 14 days, and whole lungs or bronchoalveolar lavage cells were collected. Results in Fig. 1A show that exposure to P. murina for 7 days resulted in no significant induction of Mmp12 expression in whole lungs and a minimal increase in lung lavage cells. In contrast, by 14 days postinfection, Mmp12 mRNA expression was increased by Ͼ5-fold in whole lungs and by Ͼ38-fold in lung lavage cells compared with that isolated from uninfected mice. In a separate experimental design, C57BL/6Ncr mice (NCI) were challenged with P. murina for 14 and 28 days, and whole lungs were collected. P. murina infection in this B6 strain induced significantly higher Mmp12 expression at 14 days postinfection that remained elevated through 28 days postinfection (Fig. 1B) . Thus, experimental infection with P. murina results in significant, yet time-dependent induction of Mmp12 expression in the lung.
Active MMP12 is preferentially induced in M2a AMs. We have recently reported that macrophage activation during P. murina lung infection in resistant mice favors alternative macrophage activation (28) . Although MMP12 expression may be associated with alternative macrophage activation (14) , data also support a role for IFN-␥ in the induction of MMP12 (10, 19) . CD4 T cells produce IL-4 and IFN-␥ in the lung and draining lymph nodes during P. murina lung infection with IL-4 predominating through the first 3 wk of infection (34) . Therefore, to specifically determine the pattern of MMP12 induction in M1 vs. M2a macrophage activation states, we treated AMs from naïve mice with IL-4 or IFN-␥ and determined Mmp12 mRNA and MMP12 protein levels. Results in Fig. 2A demonstrate that IL-4 was a potent inducer of Mmp12 mRNA expression, whereas IFN-␥ surprisingly downregulated Mmp12 mRNA expression. Examination of whole cell lysates for MMP12 protein levels revealed that AMs cultured overnight in medium alone produced high levels of the 45-kDa NH 2 -terminal active form of MMP12, low levels of the 54-kDa proenzyme form, and no detectable levels of the 22-kDa processed active form (Fig. 2B) . In contrast, although IL-4 pretreatment resulted in no change in the 45-kDa form, significant production of both the 54-and 22-kDa forms was observed (Fig. 2C) . IFN-␥ pretreatment had no effect on the levels of the 45-kDa form and did not induce either the 54-or 22-kDa forms. Quantitative analysis indicated that IL-4 pretreatment results in a more than eightfold and sevenfold increase in the 54-and 22-kDa forms, respectively (Fig. 2C) . Thus, the induction of fully active MMP12 during P. murina lung infection is a parameter of M2a macrophage activation.
Differential expression of Mmp12 in P. murina-infected Src-deficient vs. CD4-depleted mice. We have previously reported that mice deficient in the myeloid Src family kinases Hck, Fgr, and Lyn (Src TKO mice) demonstrated an increase in alternatively activated macrophages (28) , which we have demonstrated to have an enhanced capacity to kill P. murina (28, 29) . Because Src TKO mice are more resistant to P. murina lung infection (29), we questioned whether this observation correlated with Mmp12 expression. Results in Fig. 3A show that Src TKO mice had increased Mmp12 expression in the lungs 7 days after P. murina lung challenge, a time point at which M2 signature genes are increased (28) . It is important to note that Src TKO mice had enhanced Mmp12 expression by day 7, which is a week earlier than wild-type control mice express significant Mmp12 in the lungs (Fig. 1) . Depletion of CD4 T cells in experimental animal models leads to an inability to clear P. murina from the lungs (1). Because Mmp12 expression was elevated in mice with augmented P. murina clearance [Src TKO (29) ], we next determined whether Mmp12 expression Fig. 2 . Active MMP12 is preferentially induced in M2 alveolar macrophages. A: alveolar macrophages were isolated from 6-to 8-wk-old, male C57BL/6 via bronchoalveolar lavage and cultured in medium alone or in the presence of interleukin (IL)-4 or interferon (IFN)-␥ (10 ng/ml) for 4 h. Thereafter, total RNA was isolated and transcribed to cDNA, and quantitative real-time PCR was performed for Mmp12. Gene expression was normalized to Gapdh, and fold changes between untreated (set at 1) and infected mice were determined using the 2 Ϫ(⌬⌬Ct ) method. B: alveolar macrophages were isolated from 6-to 8-wk-old, male C57BL/6 mice and cultured in medium alone or in the presence of IL-4 or IFN-␥ (10 ng/ml) for 24 h. Thereafter, cell lysates were extracted, subjected to SDS-PAGE and polyvinylidene difluoride (PVDF) transfer, and immunoblotted with anti-murine MMP12 IgG. Positive bands were identified using an enhanced chemiluminescence (ECL) Western blot detection kit and subsequently analyzed using Quantity One 1-D Analysis Software (Bio-Rad). A representative image of MMP12 levels in unstimulated vs. IL-4-or IFN-␥-stimulated alveolar macrophages is shown (two lanes included IL-4-treated cells). Un, untreated. C: cumulative data from four independent studies employing Quantity One 1-D software to determine the densitometry values for the different MMP12 isoforms and their ␤-actin controls. Data are expressed as fold change of MMP12 to actin after normalizing unstimulated samples to a value of 1. *P value of Ͻ0.05 (paired 2-tailed Student's t-test). 5 Pneumocystis cysts via intratracheal inoculation. Seven or fourteen days postinoculation, lung cells were isolated by bronchoalveolar lavage, or whole lungs were extracted. Total RNA was isolated and transcribed to cDNA, and quantitative real-time PCR was performed for Mmp12. Gene expression was normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh), and fold changes between naïve (set at 1) and infected mice were determined using the 2 Ϫ(⌬⌬Ct ) method. Cumulative data from two independent studies with an n ϭ 4 -5 mice per group/per study are shown. B: C57BL/6Ncr mice (NCI) were similarly inoculated with P. murina, and whole lungs were collected at 14 and 28 days postinoculation. Mmp12 levels were quantified as in A. P value of Ͻ0.05 (*) and Ͻ0.001 (***) (paired 2-tailed Student's t-test).
was modulated in mice with defective P. murina clearance (i.e., CD4-depleted mice). Results in Fig. 3B show that whole lung Mmp12 expression is reduced significantly in P. murina-exposed mice subjected to depletion of CD4ϩ T cells. CD4 depletion also resulted in significantly lower expression of other M2 markers, such as RELM-␣ (Fig. 3C) and CCL17 (Fig. 3D) . Thus, Mmp12 induction in the lungs during P. murina infection directly correlates to the magnitude of the M2 response, which is dependent on CD4ϩ T cells.
Both STAT4 and STAT6 are required for optimal Mmp12 induction during P. murina lung infection. Our data support a role for IL-4 signaling and M2a AMs in the generation of lung Mmp12 expression after P. murina exposure. Moreover, CD4 T cells are required for maintaining M2 polarization and Mmp12 expression during P. murina lung infection (Fig. 3) .
Recent studies have implicated a role for IL-17A in the induction of Mmp12 expression in the lungs during cigarette smoke exposure (5, 33) . IL-17A production by CD4 T cells requires IL-23-mediated activation of the transcription factors STAT3 and STAT4 (21, 40) . Because IL-4 signals through STAT6 (15), we determined the relative contribution of STAT4 and STAT6 in Mmp12 expression during P. murina lung infection. Results in Fig. 4 show that mice deficient in STAT4 had a moderate, yet significant, reduction in lung Mmp12 expression 14 days post-P. murina challenge. However, Mmp12 expression 14 days post-P. murina challenge was more dependent on STAT6 signaling, since STAT6-deficient mice demonstrated a more marked reduction (Ϸ2.3-fold). Thus, Mmp12 expression during P. murina lung infection requires STAT6, and to a lesser extent STAT4. 5 Pneumocystis cysts via intratracheal inoculation. Seven days postinoculation, whole lungs were extracted, total RNA was isolated and transcribed to cDNA, and quantitative real-time PCR was performed for Mmp12. Gene expression was normalized to Gapdh, and fold changes between WT (set at 1) and infected Src TKO mice were determined using the 2 Ϫ(⌬⌬Ct ) method. Data from one experiment are shown (each circle or square represents an individual mouse). ***P value of Ͻ0.001 (paired 2-tailed Student's t-test). B: C57BL/6 mice were administered GK 1.5 CD4-depleting antibodies (0.3 mg, 200 l ip) 2 days before infection and weekly thereafter. Fourteen days postinoculation, whole lungs were extracted, total RNA was isolated and transcribed to cDNA, and quantitative real-time PCR was performed for Mmp12. Gene expression was normalized to Gapdh, and fold changes between untreated (set at 1) and infected CD4-depleted mice were determined using the 2 Ϫ(⌬⌬Ct ) method. Cumulative data from two independent studies with an n ϭ 4 mice per group/per study are shown. ***P value of Ͻ0.001 (paired 2-tailed Student's t-test). C and D: mice were infected as described, and 14 days postinoculation, the lungs were collected and homogenized in PBS supplemented with Complete Mini protease inhibitor tablets and supernatants were clarified by centrifugation. RELM-␣ (C) and CCL17 (D) levels were determined in clarified lung homogenate supernatants by enzyme-linked immunosorbent assay (ELISA). Cumulative data from two independent studies with an n ϭ 4 -5 mice per group/per study are shown. Data are expressed as mean pg/ml ϩ SE. P value of Ͻ0.01 (**) and 0.001 (***) (unpaired two-tailed Student's t-test).
MMP12 does not contribute to lung host defense against P. murina. Recent studies have reported that MMP12 expressed in macrophage phagolysosomes has potent antimicrobial activity (12) . Moreover, data presented in Fig. 4 suggest that the ability to clear P. murina from the lungs correlates with the level of Mmp12 induction, indicating the possibility that MMP12 may function in a host defense capacity. To address this, we challenged Mmp12 Ϫ/Ϫ mice with P. murina and assessed the burden after 7 and 14 days. Results in Fig. 5A show that, despite the ability of P. murina to induce Mmp12 expression in the lungs, MMP12 is not required for clearance of P. murina from the lungs. Moreover, MMP12 deficiency had no effect on the lung inflammatory response to P. murina in that IL-1, granulocyte-macrophage colony-stimulating factor (G-CSF), CCL2, and CXCL1 were not modulated in Mmp12 Ϫ/Ϫ mice at 7 (Fig. 5B) and 14 (Fig. 5C ) days postinfection. Thus, although Mmp12 expression is induced readily in M2a AMs during P. murina lung infection, MMP12 plays no role in immune-mediated clearance of P. murina.
DISCUSSION
COPD patients colonized with P. jirovecii are reported to have higher proinflammatory cytokine levels than noncolonized patients (3) . In experimental models, Pneumocystis infection in mice exposed to cigarette smoke results in airspace enlargement and increased inflammation (6), whereas simian/ human immunodeficiency virus-infected/Pneumocystis-colonized primates developed progressive obstructive pulmonary disease characterized by increased emphysematous tissue (35) . Collectively, clinical and experimental data indicate that Pneumocystis is associated with higher inflammation and decrements in lung function that contribute to the physiopathology and progression of COPD. In addition, we have previously reported that P. jirovecii colonization in HIV-positive COPD patients is associated with worse airway obstruction and correlates with increased levels of MMP12 in sputum (25) . In the current report, we show that the induction of MMP12 expression in the lungs is part of the normal immune response to experimental Pneumocystis infection.
In our initial analysis, we observed a relative delay in the induction of Mmp12 expression in the lungs after P. murina challenge. By 1 wk postchallenge, there was no significant change in the expression of Mmp12. However, by 2 wk postchallenge, we observed robust upregulation of Mmp12 mRNA expression in both whole lungs and bronchoalveolar lavage cells in which the largest cellular constituent was AMs (unpublished data). Mmp12 mRNA expression was enriched in bronchoalveolar lavage cells compared with whole lungs, sug- Ϫ/Ϫ mice were administered 2 ϫ 10 5 Pneumocystis cysts via intratracheal inoculation. Seven or fourteen days postinoculation, lungs were collected, and Pneumocystis burden was determined by real-time PCR for Pneumocystis rRNA copy number. Representative data from one of two independent studies with an n ϭ 5 mice per group per time point are shown. Data are expressed as mean Pneumocystis rRNA copy number. KO, knockout. B and C: mice were infected as described. At 7 (B) or 14 (C) days postchallenge, lungs were collected, and clarified supernatants from lung homogenates were analyzed for granulocyte macrophage colony-stimulating factor (G-CSF), CXCL1, CCL2, and IL-1␤ levels by Bio-Plex. Representative data from one of two independent studies with an n ϭ 5 mice per group per time point are shown. Data are expressed as mean pg/ml ϩ SE. 5 Pneumocystis cysts via intratracheal inoculation. Fourteen days postinoculation, whole lungs were extracted, total RNA was isolated and transcribed to cDNA, and quantitative real-time PCR was performed for Mmp12. Gene expression was normalized to Gapdh, and fold changes between BALB/c (set at 1) and infected Stat4-and Stat6-deficient mice were determined using the 2 Ϫ(⌬⌬Ct ) method. Cumulative data from two independent studies with an n ϭ 4 -5 mice per group/per study are shown. P value of Ͻ0.05 (*) and 0.001 (***) (paired 2-tailed Student's t-test).
gesting that structural cells such as epithelial cells or fibroblasts were likely not a significant source of Mmp12. Moreover, Mmp12 expression was not transient, since 4 wk post-P. murina challenge, Mmp12 mRNA levels remained elevated. We have recently reported that alternative macrophage activation is a component of the lung immune response to P. murina in normal mice and is enhanced in mice that demonstrate increased resistance to P. murina (28) . Because alternative (M2a) vs. classical (M1) macrophage activation is driven by IL-4 and IFN-␥, respectively, we determined whether these mediators modulated Mmp12 expression. Indeed, Mmp12 expression was favored by M2 AMs, since IL-4 treatment significantly upregulated Mmp12 expression and MMP12 protein production. It was interesting to note that IL-4 treatment specifically induced more total, i.e., unprocessed (54 kDa), MMP12 protein levels than IFN-␥. Consequently, only fully processed, active MMP12 (22 kDa) was observed in IL-4-treated AMs.
We next determined whether specific components of the immune system modulated Mmp12 expression. We first examined mice deficient in the myeloid Src family tyrosine kinases Hck, Fgr, and Lyn, since we have previously reported that these mice had higher AM effector function against P. murina and were more resistant to infection (29) . Moreover, we have shown that these mice demonstrate enhanced M2a macrophage polarization during P. murina lung infection (28) . In line with this, we found that Mmp12 expression was also elevated in these mice. We also observed a direct effect of CD4 T cell depletion on Mmp12 expression, since elimination of this cell population resulted in significantly lower Mmp12 expression. Of note, we further discovered that additional M2a macrophage activation markers, RELM-␣ and CCL17 specifically, were also reduced in CD4-depleted mice. These results indicate that CD4 T cells are required for maintaining M2a macrophage polarization during P. murina lung infection. Because we have shown that M2a AMs are potent effector cells against P. murina (28, 29) , it is possible that one mechanism contributing to the development of fulminant P. murina lung infection during CD4 T cell depletion is the loss of M2a macrophage polarization. Furthermore, our data suggest that STAT6, and to a lesser extent STAT4, are required for optimal lung Mmp12 expression during P. murina infection. Collectively, our data point to Src tyrosine kinases, CD4 T cells and STAT6, contributing to the magnitude of Mmp12 expression in the lung during P. murina infection. Our data suggested that the level of Mmp12 expression correlated with the level of P. murina clearance from the lungs, thus bringing into question whether MMP12 possessed the ability to directly inhibit the growth of P. murina. Indeed, a 20-amino acid sequence in the carboxy-terminal domain of MMP12 has been shown to be a potent growth inhibitor of multiple Gram-positive and Gram-negative bacteria (12) . The proenzyme form of MMP12 is secreted and subsequently activated in the phagolysosome of macrophages (12) . Because we have shown that blocking phagocytosis inhibits AM-mediated killing of P. murina (38) , we hypothesized that MMP12 was a mediator involved in the killing process. AMs from MMP12-deficient mice demonstrated no impairment in P. murina killing in vitro (data not shown), and we failed to observe an effect of Mmp12 deficiency on clearance of P. murina from the lungs, even at time points in which Mmp12 was highly expressed. There was also no effect on Mmp12 deficiency on the lung inflammatory response to P. murina. Although we cannot exclude the possibility that immunosuppressed MMP12-deficient mice (CD4-depleted, steroid-treated, etc.) would demonstrate a clearance defect compared with immunosuppressed control mice, our data indicate that, in immunocompetent mice, MMP12 is not required for P. murina clearance.
In summary, we took a bedside-to-bench approach to better understand the association between Pneumocystis colonization and elevated MMP12 levels. Our data show that MMP12 is induced primarily in alternatively activated (M2a) AMs in a CD4-dependent, STAT6-dependent manner during P. murina lung infection. However, MMP12 is not required for the elimination of P. murina from the lungs. Collectively, these results suggest that a consequence of P. murina lung infection is the normal development of alternatively activated AMs, a component of which is MMP12 production. Acknowledging the pathogenic association of MMP12 with COPD, our data provide critical insight into why Pneumocystis colonization may be associated with this lung disease. 
